BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19817644)

  • 1. Molecular diagnostics in acute leukemias.
    Bacher U; Schnittger S; Haferlach C; Haferlach T
    Clin Chem Lab Med; 2009; 47(11):1333-41. PubMed ID: 19817644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern diagnostics in acute leukemias.
    Haferlach T; Kern W; Schnittger S; Schoch C
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study for evaluation of different diagnostic approaches in acute leukemia in Egypt.
    Mahmoud LA; Shamaa SS; Salem MA; Aladle DA; Goda EF
    Hematology; 2006 Apr; 11(2):87-95. PubMed ID: 16753847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
    Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
    Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology strategies to detect residual disease.
    Garcés-Eisele J
    Hematology; 2012 Apr; 17 Suppl 1():S66-8. PubMed ID: 22507783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics of acute leukemias: interaction of phenotypic and genetic methods].
    Bacher U; Haferlach C; Schnittger S; Kern W; Ott MM; Haferlach T
    Pathologe; 2012 Nov; 33(6):528-38. PubMed ID: 23085696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of minimal residual disease in acute myelogenous leukemia.
    Raanani P; Ben-Bassat I
    Acta Haematol; 2004; 112(1-2):40-54. PubMed ID: 15179004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia.
    Ziai JM; Siddon AJ;
    Am J Clin Pathol; 2015 Oct; 144(4):539-54. PubMed ID: 26386075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of detecting WT1 expression in childhood acute leukemias.
    Hu SY; Gu WY; Chen ZX; Wang XL; Cen JN; He HL; Chai YH; Chen CS
    Pediatr Hematol Oncol; 2010 Nov; 27(8):581-91. PubMed ID: 20863155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute myeloid leukemia].
    Döhner K; Paschka P; Döhner H
    Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
    Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
    Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of molecular genetic investigations in the diagnosis of acute leukemias and in the detection of minimal residual disease].
    Földi J; Páldi HP; Nahajevszky S; Jakab K; Regéczi N; Pálóczi K
    Orv Hetil; 2001 May; 142(21):1097-102. PubMed ID: 11449838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidisciplinary diagnostics in acute leukemia].
    Hokland P; Pedersen B; Bendix K; Koch JE; Pallisgaard N
    Ugeskr Laeger; 1998 Sep; 160(38):5473-8. PubMed ID: 9763918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of multiparameter flow cytometry for disease monitoring in AML.
    Kern W; Bacher U; Haferlach C; Schnittger S; Haferlach T
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):379-90. PubMed ID: 21112037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X; Du W; Liu W; Li X; Li H; Huang SA
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory.
    Blombery P; Jones K; Doig K; Ryland G; McBean M; Thompson E; Yannakou CK; Westerman D
    Arch Pathol Lab Med; 2018 May; 142(5):606-612. PubMed ID: 29425073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.